These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26664934)

  • 1. Osteonecrosis of the Jaws in Dogs in Previously Irradiated Fields: 13 Cases (1989-2014).
    Nemec A; Arzi B; Hansen K; Murphy BG; Lommer MJ; Peralta S; Verstraete FJ
    Front Vet Sci; 2015; 2():5. PubMed ID: 26664934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
    Mavrokokki T; Cheng A; Stein B; Goss A
    J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
    Khan AA; Sándor GK; Dore E; Morrison AD; Alsahli M; Amin F; Peters E; Hanley DA; Chaudry SR; Dempster DW; Glorieux FH; Neville AJ; Talwar RM; Clokie CM; Al Mardini M; Paul T; Khosla S; Josse RG; Sutherland S; Lam DK; Carmichael RP; Blanas N; Kendler D; Petak S; St-Marie LG; Brown J; Evans AW; Rios L; Compston JE;
    J Rheumatol; 2008 Jul; 35(7):1391-7. PubMed ID: 18528958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Radiation-Related Osteonecrosis of the Jaws in Dogs: 14 Cases (1996-2014).
    Peralta S; Arzi B; Nemec A; Lommer MJ; Verstraete FJ
    Front Vet Sci; 2015; 2():7. PubMed ID: 26664936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteonecrosis of the jaws by intravenous bisphosphonates and osteoradionecrosis: a comparative study.
    Bagan JV; Jiménez Y; Hernández S; Murillo J; Díaz JM; Poveda R; Carbonell E; Sanchis JM; Gavaldá C; Scully C
    Med Oral Patol Oral Cir Bucal; 2009 Dec; 14(12):e616-9. PubMed ID: 19949369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
    Boonyapakorn T; Schirmer I; Reichart PA; Sturm I; Massenkeil G
    Oral Oncol; 2008 Sep; 44(9):857-69. PubMed ID: 18282788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteonecrosis of the jaw in patients on bisphosphonate treatment. review of literature with contribution of a case of multiple myeloma.
    Goranova-Marinova VS; Pechalova-Petrova PF; Goranov SG
    Folia Med (Plovdiv); 2009; 51(4):53-7. PubMed ID: 20232660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Clinical Trials on Osteonecrosis of the Jaw.
    Wu BW; Lee KC; Halepas S; Karlis V
    Cureus; 2021 Sep; 13(9):e17984. PubMed ID: 34660159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an algorithm ascertaining cases of osteonecrosis of the jaw in the Swedish National Patient Register.
    Bergdahl J; Jarnbring F; Ehrenstein V; Gammelager H; Granath F; Kieler H; Svensson M; Tell GS; Lagerros YT
    Clin Epidemiol; 2013; 5():1-7. PubMed ID: 23323023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteonecrosis of the jaw onset times are based on the route of bisphosphonate therapy.
    Fleisher KE; Jolly A; Venkata UD; Norman RG; Saxena D; Glickman RS
    J Oral Maxillofac Surg; 2013 Mar; 71(3):513-9. PubMed ID: 22999296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan.
    Ripamonti CI; Maniezzo M; Campa T; Fagnoni E; Brunelli C; Saibene G; Bareggi C; Ascani L; Cislaghi E
    Ann Oncol; 2009 Jan; 20(1):137-45. PubMed ID: 18647964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition.
    Migliario M; Mergoni G; Vescovi P; Martino I; Alessio M; Benzi L; Renò F; Fusco V
    Dent J (Basel); 2017 Mar; 5(1):. PubMed ID: 29563419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks for jaw osteonecrosis drastically increases after 2 years of bisphosphonate therapy.
    Akintoye SO; Hersh EV
    J Evid Based Dent Pract; 2012 Sep; 12(3 Suppl):251-3. PubMed ID: 23253854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dental and periodontal history of oncologic patients on parenteral bisphosphonates with or without osteonecrosis of the jaws: a pilot study.
    Carmagnola D; Celestino S; Abati S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):e10-5. PubMed ID: 18801674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR Dental PBRN.
    Barasch A; Cunha-Cruz J; Curro FA; Hujoel P; Sung AH; Vena D; Voinea-Griffin AE; Beadnell S; Craig RG; DeRouen T; Desaranayake A; Gilbert A; Gilbert GH; Goldberg K; Hauley R; Hashimoto M; Holmes J; Latzke B; Leroux B; Lindblad A; Richman J; Safford M; Ship J; Thompson VP; Williams OD; ; Wanrong Y
    Tex Dent J; 2013 Apr; 130(4):299-307. PubMed ID: 23767159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment.
    Otto S; Schreyer C; Hafner S; Mast G; Ehrenfeld M; Stürzenbaum S; Pautke C
    J Craniomaxillofac Surg; 2012 Jun; 40(4):303-9. PubMed ID: 21676622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease.
    Soundia A; Hadaya D; Esfandi N; de Molon RS; Bezouglaia O; Dry SM; Pirih FQ; Aghaloo T; Tetradis S
    Bone; 2016 Sep; 90():133-41. PubMed ID: 27327410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor subsites and risk of osteoradionecrosis of the jaw in patients with oral cavity cancer: a national-based cohort study.
    Liao PH; Chu CH; Hung YM; Tang PL; Kuo TJ
    Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3425-3433. PubMed ID: 33389009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
    O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.